Considering that deletion of PT53 partly salvages cell proliferation and apoptosis, the moderate effect of another pan-inhibitor, SAHA, towards tumor progression prevention, in a mice xenograft model with p53-depleted BCC cells is well-founded [59]. Here, TP53 is linked to neoplasm.